Achiko AG - Crunchbase Company Profile & Funding
Achiko AG (SIX: ACHI.SW) is developing disruptive diagnostic solutions that puts people first. Invented by Dr Michael Edel, the company’s flagship product is a fast, friendly, affordable and accurate Covid-19 test with a companion app.
Achiko AG: Achiko secures up to CHF12m equity and ... - Markets …
Apr 20, 2022 · Achiko AG (SIX: ACHI.SW; OTCQB: ACHKF; www.achiko.com) is developing disruptive diagnostic solutions that puts people first. The company's lead product is a rapid, reliable Covid-19 test with...
ACHIKO - LinkedIn
Achiko AG (SIX: ACHI.SW) is developing disruptive diagnostic solutions that puts people first. Invented by Dr Michael Edel, the company’s flagship product is a fast, friendly, affordable and...
Achiko AG Commences Commercial Deliveries in Indonesia
Nov 14, 2022 · Achiko AG (SIX: ACHI.SW; OTCQB: ACHKF; www.achiko.com) is developing disruptive diagnostic solutions that put people first. The Companys lead product, AptameX, is a rapid, reliable Covid-19...
Achiko AG Production and Company Update - GlobeNewswire
Nov 2, 2022 · Achiko AG (SIX: ACHI.SW; OTCQB: ACHKF; www.achiko.com) is developing disruptive diagnostic solutions that put people first. The Company’s lead product, AptameX™, is a rapid, reliable Covid-19...
Achiko AG’s Shares Begin Trading on the OTCQB Market
Dec 20, 2021 · Achiko AG (SIX: ACHI.SW; OTCQB: ACHKF; www.achiko.com) is developing disruptive diagnostic solutions that puts people first. The company’s lead product is a rapid, reliable Covid-19 test with a...
ACHI.SW Interactive Stock Chart - Yahoo Finance
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Achiko AG - Company Profile and News - Bloomberg Markets
Achiko AG provides disruptive diagnostic solutions. The Company creates and develops aptamer-based diagnostics and diagnostic testing for a range of pathogenic diseases and therapeutic...
Achiko AG - Drug pipelines, Patents, Clinical trials - Synapse
ABOUT ACHIKO AGAchiko AG (SIX: ACHI.SW; OTCQB: ACHKF; www.achiko.com) is developing disruptive diagnostic solutions that put people first. The Company’s lead product, AptameX™, is a rapid, reliable Covid-19 test with a companion app, Teman Sehat™, offering a user-friendly digital health passport.
ACHI.SW Overview | Achiko AG (ACHI.SW) - valueinvesting.io
The overview of Achiko AG (ACHI.SW) Period Debt - Book Value Equity - Book Value; 2022-06-30: 2022-03-31: 2021-12-31
- Some results have been removed